AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
BURKITTS-LYMPHOMA INVOLVING THE MANDIBLE - REPORT OF A CASE AND REVIEW OF JAPANESE CASES
Authors: HANAZAWA T KIMURA Y SAKAMAKI H YAMAGUCHI A NAGUMO M OKANO T
Citation: T. Hanazawa et al., BURKITTS-LYMPHOMA INVOLVING THE MANDIBLE - REPORT OF A CASE AND REVIEW OF JAPANESE CASES, Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 85(2), 1998, pp. 216-220
UTILITY AND SAFETY OF HICKMAN CATHETERS FOR VENOUS ACCESS AFTER BONE-MARROW TRANSPLANTATION
Authors: KUMAGAI T SAKAMAKI H TANIKAWA S AKIYAMA H MAEDA Y SASAKI T TSUZUKI S TAKAMOTO S TAKAHASHI K ONOZAWA Y
Citation: T. Kumagai et al., UTILITY AND SAFETY OF HICKMAN CATHETERS FOR VENOUS ACCESS AFTER BONE-MARROW TRANSPLANTATION, Internal medicine, 37(3), 1998, pp. 286-291
INCIDENCE AND INFLUENCE OF GB-VIRUS-C AND HEPATITIS-C VIRUS-INFECTIONIN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION
Authors: AKIYAMA H NAKAMURA N TANIKAWA S SAKAMAKI H ONOZAWA Y SHIBAYAMA T TANAKA S TSUDA F OKAMOTO H MIYAKAWA Y MAYUMI M
Citation: H. Akiyama et al., INCIDENCE AND INFLUENCE OF GB-VIRUS-C AND HEPATITIS-C VIRUS-INFECTIONIN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21(11), 1998, pp. 1131-1135
BETA-1 INTEGRINS IN A TRANSPLANTED CARTILAGINOUS TUMOR AND CULTURED-CELLS
Authors: FUKUDA M YAGAMI K SAKAMAKI H KAKUTA S NAGUMO M
Citation: M. Fukuda et al., BETA-1 INTEGRINS IN A TRANSPLANTED CARTILAGINOUS TUMOR AND CULTURED-CELLS, Journal of dental research, 77, 1998, pp. 2762-2762
PROSPECTIVE ANALYSIS OF AUTOANTIBODIES TO ICA512 AND PHOGRIN AFTER THE ONSET OF TYPE-1 DIABETES
Authors: KAWASAKI E SERA Y OZAKI M ABE T TAKINO H YAMASAKI H SAKAMAKI H KONDO H YAMAGUCHI Y AKAZAWA S EGUCHI K
Citation: E. Kawasaki et al., PROSPECTIVE ANALYSIS OF AUTOANTIBODIES TO ICA512 AND PHOGRIN AFTER THE ONSET OF TYPE-1 DIABETES, Diabetes, 47, 1998, pp. 770-770
THE NATIONWIDE PREVENTION STUDY OF TYPE-1 NIDDM IN JAPAN
Authors: TAKINO H YAMASAKI H OZAKI M ABE T SERA Y KONDO H SAKAMAKI H AKAZAWA S EGUCHI K NAGATAKI S YAMAGUCHI Y
Citation: H. Takino et al., THE NATIONWIDE PREVENTION STUDY OF TYPE-1 NIDDM IN JAPAN, Diabetes, 47, 1998, pp. 871-871
INVASIVE INFECTION DUE TO TRICHOSPORON-CUTANEUM IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: KATAOKANISHIMURA S AKIYAMA H SAKU K KASHIWA M MORI S TANIKAWA S SAKAMAKI H ONOZAWA Y
Citation: S. Kataokanishimura et al., INVASIVE INFECTION DUE TO TRICHOSPORON-CUTANEUM IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Cancer, 82(3), 1998, pp. 484-487
EFFECT OF CONTINUOUS INTRAVENOUS ADMINISTRATION OF HIGH-DOSE G-CSF ONHEMATOLOGIC RECOVERY FOLLOWING AUTOLOGOUS PURGED BONE-MARROW TRANSPLANTATION
Authors: TANIKAWA S SAKAMAKI H AKIYAMA H ONOZAWA Y KAKU H SASAKI T TAKAMOTO S ADACHI Y NARA N
Citation: S. Tanikawa et al., EFFECT OF CONTINUOUS INTRAVENOUS ADMINISTRATION OF HIGH-DOSE G-CSF ONHEMATOLOGIC RECOVERY FOLLOWING AUTOLOGOUS PURGED BONE-MARROW TRANSPLANTATION, International journal of oncology, 11(6), 1997, pp. 1355-1361
CASE-CONTROL STUDY OF LEUKEMIA AND DIAGNOSTIC RADIATION EXPOSURE
Authors: YUASA H HAMAJIMA N UEDA R OHNO R ASOU N UTSUNOMIYA A OGURA M TAKIGAWA N UEDA T HIRAOKA A MATSUDA S KURAISHI Y NISHIKAWA K UIKE N TAKESHITA A TAKEMOTO Y SHIMAZAKI C SAKAMAKI H INO T MATSUSHIMA T KURIYAMA K HIRAI H NAOE T TSUBAKI K TAKAHASHI M TAKEYAMA K MORISHIMA Y ITOH K OMOTO E HODOHARA K TAKAHASHI I
Citation: H. Yuasa et al., CASE-CONTROL STUDY OF LEUKEMIA AND DIAGNOSTIC RADIATION EXPOSURE, International journal of hematology, 65(3), 1997, pp. 251-261
OXYGEN-INDUCED EMBRYOPATHY AND THE SIGNIFICANCE OF GLUTATHIONE-DEPENDENT ANTIOXIDANT SYSTEM IN THE RAT EMBRYO DURING EARLY ORGANOGENESIS
Authors: ISHIBASHI M AKAZAWA S SAKAMAKI H MATSUMOTO K YAMASAKI H YAMAGUCHI Y GOTO S URATA Y KONDO T NAGATAKI S
Citation: M. Ishibashi et al., OXYGEN-INDUCED EMBRYOPATHY AND THE SIGNIFICANCE OF GLUTATHIONE-DEPENDENT ANTIOXIDANT SYSTEM IN THE RAT EMBRYO DURING EARLY ORGANOGENESIS, Free radical biology & medicine, 22(3), 1997, pp. 447-454
MORPHOLOGICAL SUBTYPING OF ACUTE MYELOID-LEUKEMIA WITH MATURATION (AML-M2) - HOMOGENEOUS PINK-COLORED CYTOPLASM OF MATURE NEUTROPHILS IS MOST CHARACTERISTIC OF AML-M2 WITH T(8-21)
Authors: NAKAMURA H KURIYAMA K SADAMORI N MINE M ITOYAMA T SASAGAWA I MATSUMOTO K TSUJI Y ASOU N KAGEYAMA SI SAKAMAKI H EMI N OHNO R TOMONAGA M
Citation: H. Nakamura et al., MORPHOLOGICAL SUBTYPING OF ACUTE MYELOID-LEUKEMIA WITH MATURATION (AML-M2) - HOMOGENEOUS PINK-COLORED CYTOPLASM OF MATURE NEUTROPHILS IS MOST CHARACTERISTIC OF AML-M2 WITH T(8-21), Leukemia, 11(5), 1997, pp. 651-655
ALL-TRANS-RETINOIC ACID THERAPY FOR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - COMPARISON WITH INTENSIVE CHEMOTHERAPY
Authors: ASOU N ADACHI K TAMURA J KANAMARU A KAGEYAMA S HIRAOKA A OMOTO E SAKAMAKI H TSUBAKI K SAITO K OHNO R
Citation: N. Asou et al., ALL-TRANS-RETINOIC ACID THERAPY FOR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - COMPARISON WITH INTENSIVE CHEMOTHERAPY, Cancer chemotherapy and pharmacology, 40, 1997, pp. 30-35
ACQUIRED STORAGE POOL DISEASE OF PLATELETS IN BONE-MARROW TRANSPLANTED PATIENTS
Authors: TANOUE K ENDO M AKIYAMA H AOKI K TANIKAWA S SAKAMAKI H ONOZAWA Y
Citation: K. Tanoue et al., ACQUIRED STORAGE POOL DISEASE OF PLATELETS IN BONE-MARROW TRANSPLANTED PATIENTS, Thrombosis and haemostasis, 1997, pp. 2424-2424
RISK-FACTORS FOR HEPATIC-VENOOCCLUSIVE-DISEASE AFTER BONE-MARROW TRANSPLANTATION - RETROSPECTIVE ANALYSIS OF 137 CASES AT A SINGLE INSTITUTION
Authors: KAMI M MORI S TANIKAWA S AKIYAMA H ONOZAWA Y TANAKA T OKAMOTO R MAEDA Y SASAKI T HAKU H MATSUURA Y HIRUMA K SAKAMAKI H
Citation: M. Kami et al., RISK-FACTORS FOR HEPATIC-VENOOCCLUSIVE-DISEASE AFTER BONE-MARROW TRANSPLANTATION - RETROSPECTIVE ANALYSIS OF 137 CASES AT A SINGLE INSTITUTION, Bone marrow transplantation, 20(5), 1997, pp. 397-402
MICROANGIOPATHY WITHOUT HEMOLYSIS IN A PATIENT FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: AKIYAMA H YOSHINAGA H ENDOU M TANIKAWA S SAKAMAKI H TANOUE K ONOZAWA Y
Citation: H. Akiyama et al., MICROANGIOPATHY WITHOUT HEMOLYSIS IN A PATIENT FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(3), 1997, pp. 261-263
COMPARISON OF CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AND CMV IN BRONCHOALVEOLAR LAVAGE FLUID FOR DIAGNOSIS OF CMV PULMONARY INFECTION AFTER BONE-MARROW TRANSPLANTATION
Authors: SAKAMAKI H YUASA K GOTO H TANIKAWA S AKIYAMA H ONOZAWA Y OKAMOTO R MAEDA Y SASAKI T KAKU H TSUZUKI S TAKAMOTO S MOCHIDA Y MINEMATSU T MINAMISHIMA Y
Citation: H. Sakamaki et al., COMPARISON OF CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AND CMV IN BRONCHOALVEOLAR LAVAGE FLUID FOR DIAGNOSIS OF CMV PULMONARY INFECTION AFTER BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(2), 1997, pp. 143-147
EFFECTS OF CYCLOSPORINE-A ON HEPATITIS-C VIRUS-INFECTION IN BONE-MARROW TRANSPLANT PATIENTS
Authors: AKIYAMA H YOSHINAGA H TANAKA T HIRUMA K TANIKAWA S SAKAMAKI H ONOZAWA Y WAKITA T KOHARA M
Citation: H. Akiyama et al., EFFECTS OF CYCLOSPORINE-A ON HEPATITIS-C VIRUS-INFECTION IN BONE-MARROW TRANSPLANT PATIENTS, Bone marrow transplantation, 20(11), 1997, pp. 993-995
TROGLITAZONE AMELIORATES INSULIN-RESISTANCE IN PATIENTS WITH WERNERS-SYNDROME
Authors: IZUMINO K SAKAMAKI H ISHIBASHI M TAKINO H YAMASAKI H YAMAGUCHI Y CHIKUBA N MATSUMOTO K AKAZAWA S TOKUYAMA K NAGATAKI S
Citation: K. Izumino et al., TROGLITAZONE AMELIORATES INSULIN-RESISTANCE IN PATIENTS WITH WERNERS-SYNDROME, The Journal of clinical endocrinology and metabolism, 82(8), 1997, pp. 2391-2395
A MUTANT HUMAN IGF-1 RECEPTOR AS A DOMINANT-NEGATIVE MUTANT IN L6 MYOBLASTS
Authors: YAMASAKI H YAMAGUCHI Y TAKINO H ABIRU N KONDO H IZUMINO K SAKAMAKI H AKAZAWA S NAGATAKI S
Citation: H. Yamasaki et al., A MUTANT HUMAN IGF-1 RECEPTOR AS A DOMINANT-NEGATIVE MUTANT IN L6 MYOBLASTS, Diabetologia, 40, 1997, pp. 599-599
GLUTATHIONE-DEPENDENT ANTIOXIDANT SYSTEM IN DIABETES-INDUCED EMBRYOPATHY
Authors: AKAZAWA S SAKAMAKI H ISHIBASHI M IZUMINO K ABIRU N KONDO H TAKINO H YAMASAKI H YAMAGUCHI Y KONDO T NAGATAKI S
Citation: S. Akazawa et al., GLUTATHIONE-DEPENDENT ANTIOXIDANT SYSTEM IN DIABETES-INDUCED EMBRYOPATHY, Diabetologia, 40, 1997, pp. 900-900
DIABETES-INDUCED EMBRYOPATHY AND GLUTATHIONE-DEPENDENT ANTIOXIDANT SYSTEM
Authors: SAKAMAKI H AKAZAWA S ISHIBASHI M IZUMINO K ABIRU N KONDO H TAKINO H YAMASAKI H YAMAGUCHI Y KONDO T NAGATAKI S
Citation: H. Sakamaki et al., DIABETES-INDUCED EMBRYOPATHY AND GLUTATHIONE-DEPENDENT ANTIOXIDANT SYSTEM, Diabetes, 46, 1997, pp. 345-345
HEPATITIS-G VIRUS-INFECTION IN BONE-MARROW TRANSPLANT PATIENTS
Authors: AKIYAMA H NAKAMURA N TANIKAWA S SAKAMAKI H ONOZAWA Y SHIBAYAMA T TANAKA S TSUDA F
Citation: H. Akiyama et al., HEPATITIS-G VIRUS-INFECTION IN BONE-MARROW TRANSPLANT PATIENTS, Blood, 90(10), 1997, pp. 4393-4393
RANDOMIZED STUDY OF INDIVIDUALIZED INDUCTION THERAPY WITH OR WITHOUT ETOPOSIDE IN ADULT ACUTE MYELOID-LEUKEMIA (EXCEPT FOR M3) (JALSG-AML92STUDY) AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: MIYAWAKI S TANIMOTO M KOBAYASHI T MINAMI S TAMURA J HATAKE K KURIYAMA K OHMOTO E SAITO K KANAMARU A OHO H OHTAKE S JINNAI I SAKAMAKI H YAMADA O ASOU N TAKAHASHI M TAKEYAMA K MATSUDA S UEDA R OHNO R
Citation: S. Miyawaki et al., RANDOMIZED STUDY OF INDIVIDUALIZED INDUCTION THERAPY WITH OR WITHOUT ETOPOSIDE IN ADULT ACUTE MYELOID-LEUKEMIA (EXCEPT FOR M3) (JALSG-AML92STUDY) AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 90(10), 1997, pp. 2244-2244
RANDOMIZED TRIALS BETWEEN BEHENOYL CYTARABINE AND CYTARABINE IN COMBINATION INDUCTION AND CONSOLIDATION THERAPY, AND WITH OR WITHOUT UBENIMEX AFTER MAINTENANCE INTENSIFICATION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA
Authors: KOBAYASHI T MIYAWAKI S TANIMOTO M KURIYAMA K MURAKAMI H YOSHIDA M MINAMI S MINATO K TSUBAKI K OHMOTO E OH H JINNAI I SAKAMAKI H HIRAOKA A KANAMARU A TAKAHASHI I SAITO K NAOE T YAMADA O ASOU N KAGEYAMA S EMI N MATSUOKA A TOMONAGA M SAITO H UEDA R OHNO R
Citation: T. Kobayashi et al., RANDOMIZED TRIALS BETWEEN BEHENOYL CYTARABINE AND CYTARABINE IN COMBINATION INDUCTION AND CONSOLIDATION THERAPY, AND WITH OR WITHOUT UBENIMEX AFTER MAINTENANCE INTENSIFICATION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA, Journal of clinical oncology, 14(1), 1996, pp. 204-213
ETOPOSIDE WITH WITHOUT G-CSF WITH BUSULFAN AND CYCLOPHOSPHAMIDE AS CONDITIONING FOR BONE-MARROW TRANSPLANTATION
Authors: KANDA Y AKIYAMA H TANIKAWA S SAKAMAKI H SASAKI T TAKAMOTO S ONOZAWA Y
Citation: Y. Kanda et al., ETOPOSIDE WITH WITHOUT G-CSF WITH BUSULFAN AND CYCLOPHOSPHAMIDE AS CONDITIONING FOR BONE-MARROW TRANSPLANTATION, American journal of hematology, 51(4), 1996, pp. 265-268
Risultati: 1-25 | 26-50 | 51-51